-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Inflammatory bowel disease (IBD) is a chronic recurrent intestinal and systemic inflammatory disease with two main phenotypes: ulcerative colitis (UC) and Crohn's disease (CD)
.
The thrombus embolism (TE) is a severe intestinal manifestations, large cohort studies from Western countries show that two to three times IBD patients with venous thromboembolism (VTE) in the incidence of non-IBD control group
Inflammatory bowel disease (IBD) is a chronic recurrent intestinal and systemic inflammatory disease with two main phenotypes: ulcerative colitis (UC) and Crohn's disease (CD)
Among 31940 patients with IBD, the incidence of TE was 1.
89%
.
In IBD and TE patients with IBD, the frequency of severe TE and TE-related mortality were 10.
As we all know, cardiovascular disease (CVS) is associated with the severity of young patients and the highest risk of death
.
The ratio of pulmonary embolism and PMV is increased in young patients, and unlike ATE, the incidence of VTE in IBD patients in Asian and Western countries is similar
It is well known that cardiovascular disease (CVS) is associated with the severity of young patients and the highest risk of death
Original source:
Katsuyoshi Ando.
A nationwide survey concerning the mortality and risk of progressing severity due to arterial and venous thromboembolism in inflammatory bowel disease in Japan.
Leave a message here